Celularity

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Celularity and other ETFs, options, and stocks.

About CELU

Celularity, Inc. is a clinical stage biotechnology company, which engages in the development of off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer and immune and infectious diseases. It operates through the following segments: Cell Therapy, BioBanking, Degenerative Disease, and Other. 

CEO
Robert Joseph Hariri Gordon
CEORobert Joseph Hariri Gordon
Employees
123
Employees123
Headquarters
Florham Park, New Jersey
HeadquartersFlorham Park, New Jersey
Founded
2016
Founded2016
Employees
123
Employees123

CELU Key Statistics

Market cap
49.34M
Market cap49.34M
Price-Earnings ratio
-0.77
Price-Earnings ratio-0.77
Dividend yield
Dividend yield
Average volume
118.65K
Average volume118.65K
High today
$2.10
High today$2.10
Low today
$2.00
Low today$2.00
Open price
$2.06
Open price$2.06
Volume
94.94K
Volume94.94K
52 Week high
$5.22
52 Week high$5.22
52 Week low
$1.00
52 Week low$1.00

People also own

Based on the portfolios of people who own CELU. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.